Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (161-170 of 337) with videos related to

Pageof 34
Sort By:
Pediatric Blood & Cancer|October 2, 2019
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohortMartin Benesch, Karolina Nemes, Petra Neumayer, et al.
Acta Neuropathologica|August 14, 2012
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutationsXiao-Yang Liu, Noha Gerges, Andrey Korshunov, et al.
Acta Neuropathologica|December 17, 2020
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient casesDörthe Holdhof, Pascal D Johann, Michael Spohn, et al.
Acta Neuropathologica|October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entityAndrey Korshunov, David Capper, David Reuss, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 18, 2015
Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entitiesAndrey Korshunov, Frederick A Jakobiec, Charles G Eberhart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomasAnat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.
Nature Communications|March 9, 2018
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesisPaola Infante, Roberta Faedda, Flavia Bernardi, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
International Journal of Cancer|April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsisUmar Khalid, Milena Simovic, Linda A Hammann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2020
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cellsEvelyn Susanto, Ana Marin Navarro, Leilei Zhou, et al.
Pageof 34

Showing results (161-170 of 337) with videos related to

Sort By:
Pageof 34
Pediatric Blood & Cancer|October 2, 2019
Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohortMartin Benesch, Karolina Nemes, Petra Neumayer, et al.
Acta Neuropathologica|August 14, 2012
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutationsXiao-Yang Liu, Noha Gerges, Andrey Korshunov, et al.
Acta Neuropathologica|December 17, 2020
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient casesDörthe Holdhof, Pascal D Johann, Michael Spohn, et al.
Acta Neuropathologica|October 21, 2015
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entityAndrey Korshunov, David Capper, David Reuss, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 18, 2015
Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entitiesAndrey Korshunov, Frederick A Jakobiec, Charles G Eberhart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomasAnat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.
Nature Communications|March 9, 2018
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesisPaola Infante, Roberta Faedda, Flavia Bernardi, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
International Journal of Cancer|April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsisUmar Khalid, Milena Simovic, Linda A Hammann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2020
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cellsEvelyn Susanto, Ana Marin Navarro, Leilei Zhou, et al.
Pageof 34